Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.11.511822Source: DataRank Database

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (92)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Abdon Iniguez,Nilamani Jena,Prasanthi Tata ORCID,Joan Liu ORCID,Arthur D. Lander ORCID

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W4306249527

National Institutes of Health

Grant: 1U54CA217378-01A1

Complexity, Cooperation and Community in Cancer

National Institutes of Health

Grant: 3P30CA062203-27S1

Clinical Trial Advancement and Development for Sarcomas

National Science Foundation

Grant: 1953410

Collaborative Research: Multiscale and Multiphasic Modeling of Single and Collective Migration in Fibrous Extracellular Matrices

National Science Foundation

Grant: 1936833

MODULUS: Data-Driven Mechanistic Modeling of Hierarchical Tissues

National Institutes of Health

Grant: 5T32GM136624-05

Mathematical, Computational and Systems Biology

National Institutes of Health

Grant: 5R01CA090576-19

STUDIES OF BCR-ABL LEUKEMOGENESIS IN MICE

National Science Foundation

Grant: 1763272

NSF-Simons Center for Multiscale Cell Fate Research

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/10/14/2022.10.11.511822.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.10.11.511822

repositoryhttps://doi.org/10.1101/2022.10.11.511822

repositoryhttps://escholarship.org/uc/item/13b0f6vk

Fields of Study

Chronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesChronic Lymphocytic Leukemia Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Myeloid leukemiaTyrosine-kinase inhibitorImatinibTyrosine kinaseSunitinibCancer researchMedicineNilotinibHaematopoiesisStem cellOncologyMyeloidInternal medicineImmunologyCancerBiologyReceptorGeneticsbcr-ablMyelopoiesis (mesh)Drug ResistanceFusion Proteins, bcr-ablTransgenicClinical Research (rcdc)Micecomputational biologyStem Cell Research - Nonembryonic - Human31 Biological sciences (for-2020)Animals (mesh)ChronicBiology (General)32 Biomedical and Clinical Sciences (for-2020)Stem Cell Research - Nonembryonic - Human (rcdc)cancer biologyCancer (rcdc)MyelopoiesisLeukemiaQRMice (mesh)Protein Kinase Inhibitors (mesh)systems biologyHematologytreatment dynamicsBiological sciencesStem Cell Research - Nonembryonic - Non-HumanStem Cell Research - Nonembryonic - Non-Human (rcdc)BCR-ABL Positive (mesh)bcr-abl (mesh)Neoplasm (mesh)QH301-705.5ScienceOncology and CarcinogenesisTransgenic (mesh)0601 Biochemistry and Cell Biology (for)610Mice, TransgenicTyrosine Kinase InhibitorsTyrosine Kinase Inhibitors (mesh)Rare Diseases (rcdc)nonlinear dynamicsRare DiseasesClinical Research42 Health sciences (for-2020)chronic myeloid leukemiaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnimalsProtein Kinase InhibitorsmouseHematology (rcdc)Biomedical and Clinical SciencesHealth sciencesFusion ProteinsCancer (hrcs-hc)Stem Cell ResearchStem Cell Research (rcdc)hematopoiesisOrphan Drug3211 Oncology and Carcinogenesis (for-2020)Drug Resistance, NeoplasmOrphan Drug (rcdc)NeoplasmBCR-ABL PositiveBiochemistry and Cell Biologymathematical modelMyelogenous

Sustainable Development Goals

SDG 0: Good health and well-being